glp-1 fitness news Casual Friday: My Week In Weight Loss, and News, Q&A Echelon Pushes into GLP-1 Space

Background/objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in treating type 2 diabetes and obesity, offering established metabolic and cardiovascular benefits

They stimulate insulin secretion and inhibit glucagon secretion by elevating e...

Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity

Genetics integration available: Add the Precision Peptide Genetic Test post-purchase ($99 one-time) for genetic insights across 14 health pathways

Reports of Ozempic mouth gum inflammation, tooth decay, and bad breath are emerging among people using GLP-1 drugs.